Skip to content

Six-monthly injectable PrEP is 89% more effective than oral PrEP in gay and bisexual men and trans people

Dr Onyema Ogbuagu of Yale School of Medicine speaking at HIV Glasgow 2024

Novel antibody-based regimen keeps HIV at bay for six months

Dr Paul Cook of East Carolina University speaking at a lectern

Statins and lifestyle changes recommended for more people living with HIV by European experts

Dr Jasmini Alagaratnam of London’s Chelsea and Westminster Hospital

One in nine gay and bisexual men using PrEP in Europe gets it through informal channels

A conference room with poster panels, and attendees moving between them.

Integrase inhibitor resistance after treatment failure more common in treatment-experienced people

Dr Mafalda Miranda of the University of Utrecht speaking at HIV Glasgow 2024

HIV status does not affect liver transplant outcomes, 15-year Spanish study finds

A conference room with poster panels and attendees moving between them

23% of people with HIV in the UK have depression or anxiety, but rates are much higher in some groups

Dr Fiona Lampe of University College London speaking at HIV Glasgow 2024

Once-weekly combination of islatravir and lenacapavir safe and effective in 48-week study

Amy Colson speaking at HIV Glasgow 2024

Much lower HIV knowledge and access to testing for people with disabilities globally

An older man sits in a wheelchair and tends to a plant in a garden.